{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:21:20Z","timestamp":1787718080197,"version":"build-2784847793"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Juvenile-onset recurrent respiratory papillomatosis (JoRRP) is a rare airway disease caused by human papillomavirus (HPV), most commonly HPV6 or HPV11. Affected children often require repeated surgical procedures, and no curative therapy exists. Off-label HPV vaccination has been proposed as an adjunctive treatment, but vaccine-induced immune responses and the relevance of circulating HPV DNA in benign disease remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We longitudinally evaluated 2 children with JoRRP who received off-label nonavalent HPV vaccination between 2020 and 2025. Serum HPV-specific binding and neutralizing antibodies were measured before vaccination and after the second and third doses using multiplex serology and a pseudovirion-based neutralization assay. During bronchoscopic follow-up, bronchoalveolar lavage fluid and available biopsy samples were analyzed for HPV DNA. In 1 patient, plasma was additionally tested for circulating HPV DNA by digital polymerase chain reaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Both children had low or undetectable HPV-specific antibodies at baseline. Vaccination induced strong binding and neutralizing antibody responses against vaccine-included HPV types. During post-vaccination follow-up of 12\u201329 months after completion of the vaccination series, HPV DNA became undetectable in bronchoalveolar lavage samples, and no new papilloma growth was observed after the last post-vaccination intervention. Circulating HPV DNA was not detected at any time point in the patient tested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Nonavalent HPV vaccination induced robust neutralizing antibody responses in children with JoRRP and was temporally associated with clinical stabilization. Larger studies are needed to clarify clinical benefit and biomarker utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005381","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:00:24Z","timestamp":1787716824000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Immunologic Response and Clinical Course After Off-label Nonavalent HPV Vaccination in Juvenile-onset Recurrent Respiratory Papillomatosis Patients"],"prefix":"10.1097","author":[{"given":"Neele M.","family":"Thurau","sequence":"first","affiliation":[{"name":"Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Tometten","sequence":"additional","affiliation":[{"name":"Institute of Virology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"L\u00fcbke","sequence":"additional","affiliation":[{"name":"Institute of Virology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9948-4567","authenticated-orcid":false,"given":"Birgitta E.","family":"Michels","sequence":"additional","affiliation":[{"name":"Division of Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-5190","authenticated-orcid":false,"given":"Daniela","family":"H\u00f6fler","sequence":"additional","affiliation":[{"name":"Division of Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4749-2666","authenticated-orcid":false,"given":"Fabian","family":"Rosing","sequence":"additional","affiliation":[{"name":"Division of Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4348-5066","authenticated-orcid":false,"given":"Peter","family":"Sehr","sequence":"additional","affiliation":[{"name":"EMBL-DKFZ Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Remke","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Neonatology and Pediatric Pneumonology, University Hospital Saarland (UKS), Homburg\/Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Timm","sequence":"additional","affiliation":[{"name":"Institute of Virology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9555-3876","authenticated-orcid":false,"given":"Steffi","family":"Silling","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Institute of Virology, National Reference Centre for Papilloma- and Polyomaviruses, University Hospital Cologne, Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0616-6963","authenticated-orcid":false,"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[{"name":"Division of Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0440-4737","authenticated-orcid":false,"given":"Dirk","family":"Schramm","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-8793","authenticated-orcid":false,"given":"Nadine","family":"Freitag","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"R1-20260826","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/coa.12565","article-title":"Age of onset of recurrent respiratory papillomatosis: a distribution analysis.","volume":"41","author":"San Giorgi","year":"2016","journal-title":"Clin Otolaryngol"},{"key":"R2-20260826","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/archotol.125.7.743","article-title":"Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP task force.","volume":"125","author":"Armstrong","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R3-20260826","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1471-0528.1994.tb13153.x","article-title":"Cancer associated human papillomaviruses: perinatal transmission and persistence.","volume":"101","author":"Pakarian","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"R4-20260826","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1743-422X-6-83","article-title":"Perinatal transmission of human papilomavirus DNA.","volume":"6","author":"Rombaldi","year":"2009","journal-title":"Virol J"},{"key":"R5-20260826","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/MLG.0b013e31816a7135","article-title":"Recurrent respiratory papillomatosis: a review.","volume":"118","author":"Derkay","year":"2008","journal-title":"Laryngoscope"},{"key":"R6-20260826","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/jpids\/piab016","article-title":"Juvenile-onset recurrent respiratory papillomatosis in the United States, epidemiology and HPV types-2015-2020.","volume":"10","author":"Amiling","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R7-20260826","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.3390\/cancers14235946","article-title":"Circulating human papillomavirus DNA in head and neck squamous cell carcinoma: possible applications and future directions.","volume":"14","author":"Adilbay","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archotol.1995.01890120044008","article-title":"Task force on recurrent respiratory papillomas. A preliminary report.","volume":"121","author":"Derkay","year":"1995","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R9-20260826","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1002\/lary.29343","article-title":"Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement.","volume":"131","author":"Sidell","year":"2021","journal-title":"Laryngoscope"},{"key":"R10-20260826","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1007\/s00405-022-07388-6","article-title":"Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review.","volume":"279","author":"Pogoda","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R11-20260826","doi-asserted-by":"crossref","first-page":"636","DOI":"10.5935\/1808-8694.20130114","article-title":"Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis.","volume":"79","author":"Avelino","year":"2013","journal-title":"Braz J Otorhinolaryngol"},{"key":"R12-20260826","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1592\/phco.2005.25.7.977","article-title":"Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.","volume":"25","author":"Shehab","year":"2005","journal-title":"Pharmacotherapy"},{"key":"R13-20260826","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S1470-2045(14)71179-9","article-title":"Next generation prophylactic human papillomavirus vaccines.","volume":"16","author":"Schiller","year":"2015","journal-title":"Lancet Oncol"},{"issue":"32 Pt A","key":"R14-20260826","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1016\/j.vaccine.2017.11.089","article-title":"Immunogenicity of HPV prophylactic vaccines: serology assays and their use in HPV vaccine evaluation and development.","volume":"36","author":"Pinto","year":"2018","journal-title":"Vaccine"},{"key":"R15-20260826","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R17-20260826","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s12931-024-03057-w","article-title":"A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis.","volume":"25","author":"Ovcinnikova","year":"2024","journal-title":"Respir Res"},{"key":"R18-20260826","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jvoice.2014.08.003","article-title":"The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma.","volume":"29","author":"Young","year":"2015","journal-title":"J Voice"},{"key":"R19-20260826","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jamaoto.2022.1190","article-title":"Outcomes after human papillomavirus vaccination in patients with recurrent respiratory papillomatosis: a nonrandomized clinical trial.","volume":"148","author":"Smahelova","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R20-20260826","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00405-016-4085-3","article-title":"Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis.","volume":"273","author":"Tjon Pian Gi","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R21-20260826","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijporl.2016.12.035","article-title":"Therapeutic use of the HPV vaccine in recurrent respiratory papillomatosis: a case report.","volume":"93","author":"Sullivan","year":"2017","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R22-20260826","doi-asserted-by":"crossref","first-page":"111314","DOI":"10.1016\/j.ijporl.2022.111314","article-title":"Systematic review of the use of human papillomavirus vaccine as adjuvant therapy for juvenile-onset recurrent respiratory papillomatosis.","volume":"162","author":"Park","year":"2022","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R23-20260826","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jviromet.2004.08.007","article-title":"Nested PCR with the PGMY09\/11 and GP5(+)\/6(+) primer sets improves detection of HPV DNA in cervical samples.","volume":"122","author":"Fuessel Haws","year":"2004","journal-title":"J Virol Methods"},{"key":"R24-20260826","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0974-777X.188591","article-title":"PCR and genotyping for HPV in cervical cancer patients.","volume":"8","author":"Prakash","year":"2016","journal-title":"J Glob Infect Dis"},{"key":"R25-20260826","doi-asserted-by":"crossref","first-page":"e57207","DOI":"10.1371\/journal.pone.0057207","article-title":"Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis.","volume":"8","author":"Huebbers","year":"2013","journal-title":"PLoS One"},{"key":"R27-20260826","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1373\/clinchem.2005.052381","article-title":"Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins.","volume":"51","author":"Waterboer","year":"2005","journal-title":"Clin Chem"},{"key":"R28-20260826","doi-asserted-by":"crossref","first-page":"e75677","DOI":"10.1371\/journal.pone.0075677","article-title":"High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.","volume":"8","author":"Sehr","year":"2013","journal-title":"PLoS One"},{"key":"R29-20260826","doi-asserted-by":"crossref","first-page":"e0002424","DOI":"10.1128\/spectrum.00024-24","article-title":"Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR.","volume":"12","author":"Rosing","year":"2024","journal-title":"Microbiol Spectr"},{"key":"R30-20260826","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol"},{"key":"R31-20260826","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/lary.23534","article-title":"Juvenile recurrent respiratory papilloma: variable intersurgical intervals.","volume":"122","author":"Ongkasuwan","year":"2012","journal-title":"Laryngoscope"},{"key":"R32-20260826","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijporl.2016.01.032","article-title":"Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis.","volume":"83","author":"Hermann","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R33-20260826","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-19-0211","article-title":"Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.","volume":"25","author":"Chera","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:00:28Z","timestamp":1787716828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005381","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}